Abstract: The present disclosure relates to a composition for the prevention, amelioration or treatment of inflammatory bowel disease, comprising a galacto-oligosaccharide as an active ingredient. The galacto-oligosaccharide composition of the present disclosure has an anti-inflammatory effect of ameliorating DAI and reducing the levels of inflammatory cytokines and MPO in inflammatory bowel disease model mice, and thus can be effectively used as a drug or food for the prevention, amelioration or treatment of inflammatory bowel disease.

Abstract: A monitoring device for measuring characteristics of an edge area of an object to be measured and a method of manufacturing the same are disclosed. The monitoring device comprises a lower cover, a guide member disposed on the lower cover, a circuit module in which at least one electrical element is disposed on a circuit board and an upper cover disposed on the guide member or the circuit module. Here, a space is formed at the guide member, and at least partial of the circuit module locates in the space.

Abstract: A rooftop tent fixing device according to an embodiment of the present disclosure includes: clamp bodies provided in a pair; fixing brackets provided on upper portions of the clamp bodies and configured to detachably connect a fixing frame provided on a bottom surface of a rooftop tent and the clamp bodies, the fixing brackets having fastening holes; fastening members inserted and fastened into the fastening holes and having through-holes; a fastening rod inserted into the through-holes to connect the clamp bodies; and a locking member detachably coupled to one of the clamp bodies and configured to prevent removal of the fastening rod when coupled to one of the clamp bodies.

Abstract: The present disclosure discloses a method for controlling entry of a traveling vehicle into an intersection according to a shaded area setting at a non-traffic light intersection and an apparatus thereof, and the method is performed by an intersection traveling control apparatus and includes setting a traveling safety area of a traveling vehicle on a precision map pre-stored in the traveling vehicle, setting a shaded area on the precision map based on data acquired through a sensor mounted on the traveling vehicle, calculating object information moving in a dangerous shaded area and setting an internal area and a virtual stop line corresponding to the object information and the dangerous shaded area, transmitting a slow-down signal and a stop signal along the virtual stop line to the traveling vehicle, and transmitting a dangerous shaded area setting release signal to the traveling vehicle based on the internal area and the object information.

Abstract: The present specification provides not only an antigen-specific T cell receptor but also a nucleic acid, a vector, and an immune cell comprising the T cell receptor, and a method using same.

Abstract: A large area monitoring device for diagnosing easily performance of an equipment in a semiconductor process or a display process is disclosed. The monitoring device comprises a protection layer, a board disposed in an internal space of the protection layer, and at least one electrical element disposed on the board. Here, the electrical element includes one or more sensors, the monitoring device monitors an object to be monitored by measuring at least one of a temperature, a slope, a light, a vibration, a voltage, current, a power or a pressure of the object located outside the monitoring device and a distance between the object and another element, an intaglio structure or an embossing structure is formed to the board, material with different characteristics from the board is filled in the intaglio structure or the embossing structure is formed of material with different characteristics from the board.

Abstract: A lane change recommendation system may include: a lane recommendation condition determination unit including a driving situation determination unit determining whether a host vehicle being driven on a driving lane satisfies driving situation conditions for lane change from the driving lane to a target lane; and a lane determination unit determining whether a lane condition for the lane change is satisfied based on a color and type of a lane between the driving lane and the target lane; and a status transition unit receiving a status indicating whether the lane change is possible from the lane recommendation condition determination unit to generate an instruction of lane recommendation.

Abstract: In the case of a gas in which several gases are mixed, a type and concentration of the gas may be incorrectly measured when measured using only an optical band-pass filter. The invention of the present application is directed to providing a technology in which a plurality of broadband band-pass filters having overlapping regions are provided to calculate a magnitude of absorption for each wavelength band for light passing through each broadband band-pass filter, thereby identifying the presence of a gas of interest and the presence of a gas other than the gas of interest.

Abstract: A method of generating a moving viewpoint motion picture, which is performed by a processor that executes at least one instruction stored in a memory, may comprise: obtaining an input image; generating a trimap from the input image; generating a depth map using the input image; generating a foreground mesh/texture map model based on a foreground alpha map obtained based on the trimap and foreground depth information obtained based on the trimap and the depth map; and generating a moving viewpoint motion picture based on the foreground mesh/texture map model.

Abstract: The present application relates to an orally administered pharmaceutical composition or kit for eradicating Helicobacter pylori, including a complex of a non-absorbable antibiotic and a clay mineral. The pharmaceutical composition and kit of the present invention may further include a ?-lactam antibiotic and/or a gastric acid inhibitor.

Abstract: A pharmaceutical composition for treating Clostridioides difficile Infection (CDI), and a method for producing same. The pharmaceutical composition includes a complex of clay minerals, such as bentonite, and antibiotics, such as vancomycin. Accordingly, the pharmaceutical composition has an excellent treatment effect on CDI even with a significantly smaller amount of each of the existing antibiotics and clay minerals than the maximum recommended daily intake thereof, and has the effect of reducing side effects that can be caused by the massive intake of the antibiotics and clay minerals.

Abstract: A device searching system and method for data transmission are provided. A method of searching for another device in a first device for data transmission includes outputting a widget window for a device search, receiving an address book stored in a second device connected to the first device, and if the widget window is selected, searching for a device included in the received address book, wherein the searching of the device includes searching for at least one of devices included in the received address book based on a keyword input through the widget window.

Abstract: Disclosed is a lamination system. A lamination system, which bonds a panel and a bonding target panel to from a panel assembly, according to one embodiment of the present invention may include a transfer which moves along a transfer shuttle and supports any one among the panel, the bonding target panel, and the panel assembly, a bonding chamber which is provided parallel to the transfer shuttle and bonds the panel and the bonding target panel, and a first robot which transfers any one among the panel, the bonding target panel, and the panel assembly between the transfer and the bonding chamber.

Abstract: According to one embodiment of the present invention, provided is a drug-clay mineral complex, in which the complex comprises a phospholipid, and the drug has an amine group.

Abstract: The present invention relates to Regentide-012 and Regentide-013 and, more specifically, to a use of Regentide-012 and Regentide-013 for improving skin conditions. Regentide-012 and Regentide-013 according to the present invention is free of cytotoxicity and have remarkable effects of skin aging reduction, skin regeneration, skin elasticity improvement, skin wrinkle prevention, skin wrinkle reduction, and skin wound recovery and as such, can be variously utilized in the pharmaceutical, medicinal, cosmetic, and food fields.

Abstract: The present invention relates to regentide-034 and, more specifically, to a use of regentide-034 for improving the condition of the skin. Regentide-034 according to the present invention is noncytotoxic and has remarkable effects of skin aging alleviation, skin regeneration, skin elasticity improvement, skin wrinkle prevention, skin wrinkle reduction and skin wound regeneration, and thus can be variously used in the fields of pharmacology, medicine, cosmetics, and food.

Abstract: The present invention relates to Regentide-034 and Regentide-041 and, more specifically, to a use of a mixture of Regentide-034 and Regentide-041 for improving skin conditions. A mixture of Regentide-034 and Regentide-041 according to the present invention is free of cytotoxicity and has remarkable effects of promoting cell proliferation and collagen synthesis, inhibiting elastase activity, and suppressing ultraviolet light-induced cell death and as such, can be variously utilized in the pharmaceutical, medicinal, cosmetic, and food fields.

Abstract: The present invention provides a substrate treating method, including: a first treatment operation of treating the substrate by using first plasma generated by exciting first gas; and a second treatment operation of treating the substrate by using second plasma generated by exciting second gas different from the first gas.

Abstract: A drug and layered silicate composite is provided. The drug and layered silicate contains layered silicate powders and a drug compound bound to between layers of the silicate powders, wherein the drug compound is present in an amorphous state in the composite. Using such a composite may significantly improve absorption and bioavailability of a sorafenib compound.

Abstract: A vehicular rooftop tent according to an embodiment of the present disclosure includes: a first cover part including a first plate member provided in a plate shape; a second cover part including a second plate member provided in a plate shape; a hinge connection part configured to rotatably connect the first cover part and the second cover part; a tent part coupled to the first cover part and the second cover part; and a waterproof part having one end fastened to the first cover part.